Skip to main content

CordenPharma in peptide expansion

CordenPharma has announced the addition of a 3,000-litre solid-phase peptide synthesis (SPPS) vessel at its GMP API facility in Boulder, Colorado. This site, which was formerly owned by Roche, already has a 10,000-litre SPPS vessel and a 100 cm high-pressure reverse phase purification column, and is claimed to have the largest capacity of any peptide API facility.

Cabot breaks ground

Cabot has broken ground on its carbon black capacity expansion project in Cilegon, Indonesia. This phase of the project will add approximately 80,000 tonnes/year of capacity for the regional market, where demand is growing by 4-5%/year. It is expected to be completed in 2021.

This is part of global capacity expansion and debottlenecking project that Cabot announced in May 2018 to increase capacity by 300,000 tonnes/year. The company said that it “has made significant progress” towards this target.

Subscribe to expansion

 

 

 

AMRI banner advert